Search for: "Celgene Corporation" Results 21 - 40 of 49
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Oct 2020, 9:45 am by Patrick A. Malone
Democrats on the House Oversight Committee are pounding Big Pharma executives for price gouging, publishing an 18-month investigation of the soaring costs of select prescription medications and grilling  high-paid corporate leaders on whether those meds’ spiking prices were all too prevalent in the profit-ravenous drug industry. [read post]
27 Aug 2009, 3:22 pm
Jacobson has now brought a lawsuit against the Celgene Corporation (Jacobson v. [read post]
28 Oct 2010, 10:14 am by FDABlog HPM
  Consider, for example, a recent quarterly report from Celgene Corporation, which states with respect to Risk Evaluation and Mitigation Strategies (“REMS”) that: In the fourth quarter of 2009, we received a civil inquiry and demand from the [Federal Trade Commission (“FTC”)]. [read post]
4 Jun 2020, 2:58 am by Dennis Crouch
Sony Corporation, No. 19-601; Celgene Corporation v. [read post]
17 Feb 2009, 2:00 pm
The balance of the ticket price is a tax deductible charitable contribution.Center for Medicine in the Public Interest, is a New York not-for-profit corporation dedicated to charitable, religious, scientific, literary and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. [read post]
3 Jun 2015, 1:40 pm by Tom Lamb
  In more detail, from the Celgene Corporation Prescribing information for Pomalyst (accessed 6/3/15): POMALYST, in combination with dexamethasone, is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy. [read post]
6 Jun 2011, 11:51 am by Christine Hurt
  Anyway, the article highlights shareholders at Celgene Corporation who have found each other on the Internet and are trying to gather enough folks together to vote down the executive compensation pay package at the upcoming annual meeting. [read post]
29 Nov 2007, 1:00 am
Also, New Jersey-based biotechnology company Celgene has purchased cancer drugmaker Pharmion for $2.9 billion. [read post]
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
10 Feb 2017, 9:46 pm by Mark Summerfield
  The Supreme Court decision was almost immediately cited by an Australian Patent Hearing Officer, who found that a claimed method for commercialising inventions does not constitute patentable subject matter under the Australian ‘manner of manufacture’ test: Invention Pathways Pty Ltd [2010] APO 10.The Invention Pathways decision resulted in an official change to Australian Patent Office practice whereby a claimed invention, to be patent-eligible, would not only need to involve a… [read post]
2 Oct 2008, 10:58 am
Gills Kaplan determined that Thalidomide inhibited tumor necrosis factor, and she partnered with Celgene Corporation to seek further development for Thalidomide. [read post]
1 Dec 2009, 9:39 am
The company has a practice of using a multitude of corporate names and billing addresses for work by its subsidiaries, creating confusion for Howrey as to who its client really was in a related European case. [read post]
30 Jan 2019, 5:44 am
M&A being lumpy and unpredictable as ever, 2019 has opened with a number of notable deals, not least the sale of Celgene to Bristol-Myers Squibb for $95 billion, somewhat defying gloomy predictions for the year. [read post]
Celgene International Holdings Corporation The Moscow City Commercial Court fulfilled a claim made by a local generic company Nativa and granted a license to use a patented drug of Celgene International Holdings Corporation in connection to the cancer drug, Lenalidomide-Nativ. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
Francis Rooney (R-FL) wrote a letter to the FTC, urging the agency to investigate Bristol-Myers Squibb Company’s (“Bristol-Myers”) acquisition of Celgene Corporation (“Celgene”). [read post]
25 Jun 2018, 3:49 am by Boris Malakhov
In doing so, the courts used to rely on Bolar Principle interpreting such clearly profit-driven actions as registration of price to be preparatory actions that cannot bear threat of infringement (Celgene Corporation vs. [read post]